Books + eBook: Application of Microorganisms in Drug Discovery and Environment Microbes Compliant with GMP
Utilization and Management of Microorganisms by Development/Manufacturing Stages - Printable
【Book + eBook】 For details and applications for this product, please check our website. https://www.science-t.com/ebook/22196.html 【Comprehensive Guide to Microorganisms in Pharmaceuticals】 "Microorganisms that are Beneficial and Harmful" Unraveling the roles and issues of pharmaceuticals and microorganisms that are inextricably linked Natural product drug discovery methods and considerations for generic production, looking ahead to active pharmaceutical ingredient production Microbial management in laboratories/manufacturing sites compliant with PIC/S - Deviations/Alerts, Actions, Monitoring - ■ Considerations for natural product drug discovery aimed at new drug and generic development Are there really no useful microorganisms left that could become new drugs... What should be known at the development stage with an eye on the manufacturing line... The microorganisms involved in past pharmaceutical development and those currently being developed... ■ Considerations for microbial management in laboratories/manufacturing sites compliant with PIC/S What is microbial testing management and how to handle re-testing/validation... What are the environmental monitoring methods that comply with the three pharmacopoeias/GMP... What are the alert/action levels and deviation responses in microbial management...
Inquire About This Product
basic information
■Authors Daisuke Fukuda, Daiichi Sankyo RD Novare Co., Ltd. Shigeo Kawada, NPO Pharmaceutical and Food Quality Assurance Support Center Daikichiro Murakami, Taikisha Ltd. ■Table of Contents Part 1: Drug Production from Microorganisms, Natural Product Drug Discovery Introduction 1. Drug Discovery from Microorganisms: Current Status of Natural Product Drug Discovery 2. Practical Aspects of Natural Product Drug Discovery 3. New Microbial Resources for Natural Product Drug Discovery Others Conclusion: The Future of Natural Product Drug Discovery Part 2: Microbial Testing Management and Re-testing/Validation in Compliance with PIC/S GMP 1. A Comparative Study of the Three Regions Based on PIC/S GMP for Aseptic Pharmaceuticals 2. Implementation of Microbial Testing 3. Out of Specification (OOS) Results of Microbial Testing and Regulations for Re-testing Others Part 3: Environmental Monitoring and Deviation Management/Alert and Action Levels in the Pharmacopoeia and GMP of the Three Regions Introduction: Concept of Deviations in the Regulations of the Three Regions 1. Locations of Deviation Expressions in EU-GMP 2. Scope of Deviation Management 3. Importance of Deviation Management Others Summary: Conclusion from USP29 <1116>
Price range
Delivery Time
Applications/Examples of results
For more details, please visit our company website.
catalog（1）
Download All Catalogs
Company information
Nowadays, information is accessible to anyone. However, it is also true that there are barriers that cannot be easily overcome, such as social status based on age, industry, government, company, position, personal connections, and geography, when it comes to acquiring what one truly desires. On the other hand, there is also a barrier where valuable information exists but cannot be communicated to those who need it. Our company aims to transcend that "wall" on behalf of everyone and provide information that connects those in need with those who can share it. 1. We provide a platform for those involved in research and technology at companies to exchange information and foster improvements and advancements in science and practical technology. 2. We offer lectures from corporate engineers and practitioners to undergraduate and graduate students in science and engineering, nurturing the next generation of young talent. 3. We provide children with books that showcase the excitement of science, technology, and the lives and work of those involved in these fields, broadening their future dreams.
![[Data] Liquid-cooled heat exchanger (liquid-liquid) / Apiste](https://image.mono.ipros.com/public/product/image/d6a/2000639677/IPROS70932606551808122289.jpeg?w=280&h=280)
![[Data] The Necessity of Non-Freonization / Apiste](https://image.mono.ipros.com/public/product/image/7e9/2000641109/IPROS09660173382881672400.jpeg?w=280&h=280)
![[Book] Introduction of DX to the Research and Development Department (No. 2150BOD)](https://image.mono.ipros.com/public/product/image/018/2000703356/IPROS05632022727105450889.jpeg?w=280&h=280)
![[Book] DX Transformation of Plants (No. 2151BOD)](https://image.mono.ipros.com/public/product/image/6c6/2000703364/IPROS14826422596978422029.gif?w=280&h=280)
